Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Irvine-based TS Pharma has entered into an agreement to commercialize and sell Radient Pharmaceuticals' Onko-Sure in Central American and Caribbean nations including.
Subscribe to our email newsletter
Under the agreement, TS Pharma will commercialize the product in Antigua, Aruba, Bahamas, Barbados, Belize, Bermuda, Cayman Islands, Costa Rica, Curacao, , Dominican Republic, Guatemala, Haiti, Honduras, Jamaica, Netherland Antilles El Salvador, Panama, and Trinidad & Tobago.
Onko-Sure detects and/or monitors 15 different types of cancers by using a simple non-invasive blood test method.
Radient chairman and CEO Douglas MacLellan said with this agreement, they are making Onko-Sure available in additional new markets.